About the Human Pharmaceuticals Business
Boehringer Ingelheim's pharmaceutical research and development capabilities are globally leading in the industry. We continuously explore groundbreaking medical innovations and provide innovative drugs to meet patient needs in key therapeutic areas such as cardiovascular diseases, respiratory diseases, metabolic diseases, immunology, oncology, and central nervous system disorders. In the future, the company plans to launch innovative products or new indications of existing products in areas such as cardiovascular metabolism, respiratory, oncology, immunology, central nervous system, and retinal diseases to meet the needs of patients in China.
About the China Center of Chemistry (CoC)
The China Center of Chemistry (CoC) is a part of Boehringer Ingelheim's human pharmaceuticals organization, providing professional technical services to both internal and external customers of Boehringer Ingelheim:1) Offering technical support to the R&D department to accelerate the launch of new products. 2) Supporting the production department by continuously optimizing the processes of existing BI products to ensure market supply. 3) Managing suppliers within China, maintaining close communication with them, and providing technical support when necessary.
The department adheres to the mission of "creating higher quality, better prices, and more choices for human health." Over the past thirteen years, it has continuously innovated and pushed its boundaries, becoming a trusted expert in process development. It provides the R&D and production departments with cost-effective, high-quality, one-stop solutions.
Responsibilities:
Job Requirements:

Our people are our strength. And together with over 54,000 colleagues, we're creating the next breakthrough in the world of healthcare and innovation for both humans and animals. Are you ready to join us? #LifeForward
Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice
Imprint: https://www.boehringer-ingelheim.com/imprint